April 2025 Edition

April 2025 Current Affairs MCQs & Solutions

Top national & international current affairs questions for CSS, PMS, FPSC, PPSC, and NTS screening tests.

Start April Quiz
#861

What major medical link was debunked by new research in November 2025 regarding a common pain reliever?

(a) Ibuprofen and kidney failure
(b) Acetaminophen (Tylenol) and autism
(c) Aspirin and heart disease
(d) Naproxen and ulcers
Explanation: New research published in November 2025 found no clear link between the use of Acetaminophen (Tylenol) during pregnancy and the development of autism in children, addressing a long-standing medical concern.
#862

In September 2025, researchers at UCLA developed a non-invasive AI 'co-pilot' to enhance which technology?

(a) MRI imaging
(b) Brain-Computer Interface (BCI)
(c) Robotic surgery
(d) Pacemakers
Explanation: UCLA engineers developed a non-invasive AI co-pilot in September 2025 that helps interpret user intent in Brain-Computer Interfaces (BCIs), significantly improving the speed and accuracy of cursor control and robotic arm manipulation.
#863

Which drug was approved in August 2025 to prevent attacks of hereditary angioedema?

(a) Dawnzera (donidalorsen)
(b) Hernexeos (zongertinib)
(c) Modeyso (dordaviprone)
(d) Vizz (aceclidine)
Explanation: Dawnzera (donidalorsen) received FDA approval in August 2025 as a prophylactic treatment to prevent attacks in patients suffering from hereditary angioedema.
#864

Scientists in November 2025 used CRISPR to boost the efficiency and digestibility of which organism to create a meat-like food source?

(a) Algae
(b) Yeast
(c) Fungus
(d) Bacteria
Explanation: Researchers used CRISPR in November 2025 to modify a specific fungus. The engineered strain grows protein faster, requires less sugar, and has a meat-like texture, offering a sustainable food alternative.
#865

Which drug, approved in July 2025, is a treatment for presbyopia (age-related loss of near vision)?

(a) Vizz (aceclidine)
(b) Anzupgo (delgocitinib)
(c) Sephience (sepiapterin)
(d) Ekterly (sebetralstat)
Explanation: Vizz (aceclidine) was approved by the FDA in July 2025 as a pharmacological treatment for presbyopia, helping to improve near vision in adults.
#866

A November 2025 study identified that massive Sargassum blooms are fueled by a nutrient partnership between the algae and which organism?

(a) Phytoplankton
(b) Cyanobacteria
(c) Krill
(d) Coral polyps
Explanation: The study revealed that the massive Sargassum seaweed blooms are fueled by nitrogen supplied by cyanobacteria living on the algae, combined with phosphorus from equatorial upwelling.
#867

What is the specific application of the drug 'Brinsupri' (brensocatib), approved in August 2025?

(a) Non-cystic fibrosis bronchiectasis
(b) Cystic fibrosis
(c) Asthma
(d) COPD
Explanation: Brinsupri (brensocatib) was approved in August 2025 for the treatment of non-cystic fibrosis bronchiectasis, marking a significant advancement for patients with this chronic lung condition.
#868

In November 2025, researchers introduced a new gel capable of regrowing which human tissue?

(a) Skin
(b) Tooth enamel
(c) Cartilage
(d) Cornea
Explanation: A new gel developed in November 2025 showed the ability to regrow tooth enamel, potentially transforming dentistry by offering a way to repair teeth without traditional fillings.
#869

Which drug received FDA approval in September 2025 for treating Barth syndrome?

(a) Forzinity (elamipretide)
(b) Keytruda Qlex
(c) Inluriyo
(d) Rhapsido
Explanation: Forzinity (elamipretide) was approved in September 2025 specifically to improve muscle strength in patients with Barth syndrome, a rare genetic disorder affecting the heart and metabolism.
#870

A November 2025 study suggested that daily consumption of what beverage could reduce the risk of Atrial Fibrillation (AFib) by 39%?

(a) Green Tea
(b) Coffee
(c) Orange Juice
(d) Pomegranate Juice
Explanation: A heart study released in November 2025 found a surprising link suggesting that daily coffee consumption could cut the risk of Atrial Fibrillation (AFib) by up to 39%.
#871

What is 'Anzupgo' (delgocitinib), approved in July 2025, used to treat?

(a) Psoriasis
(b) Chronic hand eczema
(c) Acne
(d) Rosacea
Explanation: Anzupgo (delgocitinib) was approved in July 2025 for the treatment of moderate-to-severe chronic hand eczema in adults where topical corticosteroids are ineffective or inadvisable.
#872

Which November 2025 discovery involves 'bacterial nanopores' behaving in a way similar to a brain?

(a) They can reproduce autonomously
(b) They demonstrate learning capabilities
(c) They generate electricity
(d) They communicate via radio waves
Explanation: Scientists at EPFL discovered in November 2025 that biological nanopores from bacteria can exhibit 'memory' and learning-like behaviors, similar to how brain synapses work, which could impact bio-computing.
#873

Which drug was approved in August 2025 for treating diffuse midline glioma with a specific H3 K27M mutation?

(a) Modeyso (dordaviprone)
(b) Hernexeos (zongertinib)
(c) Ibtrozi (taletrectinib)
(d) Zegfrovy (sunvozertinib)
Explanation: Modeyso (dordaviprone) was approved in August 2025 for the treatment of diffuse midline glioma, a serious brain tumor, specifically in patients harboring the H3 K27M mutation.
#874

In November 2025, scientists developed a tiny ingestible pill that detects what condition by glowing?

(a) Stomach ulcers
(b) Intestinal bleeding
(c) Colon cancer
(d) Acid reflux
Explanation: A new ingestible pill developed in November 2025 contains engineered bacteria that glow when they encounter heme, a component of blood, thereby acting as a non-invasive detector for intestinal bleeding.
#875

What is the primary function of the drug 'Inluriyo' (imlunestrant), approved in September 2025?

(a) Treating lung cancer
(b) Treating breast cancer
(c) Treating prostate cancer
(d) Treating skin cancer
Explanation: Inluriyo (imlunestrant) was approved in September 2025 for the treatment of estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer.
#876

Researchers in November 2025 found that Vitamin D3 supplementation could halve the risk of what event?

(a) Bone fracture
(b) Second heart attack
(c) Stroke
(d) Developing diabetes
Explanation: A study published in November 2025 indicated that Vitamin D3 supplementation could reduce the risk of suffering a second heart attack by approximately 50%.
#877

Which term describes the 2025 robotics trend of robots made from pliable materials to handle delicate objects?

(a) Elastic Robotics
(b) Soft Robotics
(c) Fluid Robotics
(d) Flex-Bots
Explanation: Soft Robotics is a growing trend in 2025 involving the creation of robots from soft, flexible materials. This allows them to handle delicate items like fruit or electronics without damaging them.
#878

Which drug was approved in June 2025 for treating ROS1-positive non-small cell lung cancer?

(a) Ibtrozi (taletrectinib)
(b) Andembry (garadacimab)
(c) Lynozyfic (linvoseltamab)
(d) Zegfrovy (sunvozertinib)
Explanation: Ibtrozi (taletrectinib) received FDA approval in June 2025 for the treatment of patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer.
#879

In November 2025, a new airflow device was introduced that can capture indoor germs almost immediately. Which university's engineers developed it?

(a) MIT
(b) UBC Okanagan
(c) Stanford
(d) Oxford
Explanation: Engineers at the University of British Columbia (UBC) Okanagan developed a new airflow device in November 2025 that traps exhaled aerosols and pathogens almost immediately to prevent disease spread indoors.
#880

Which drug was approved in July 2025 to treat relapsed or refractory multiple myeloma?

(a) Lynozyfic (linvoseltamab)
(b) Ekterly (sebetralstat)
(c) Zegfrovy (sunvozertinib)
(d) Anzupgo (delgocitinib)
Explanation: Lynozyfic (linvoseltamab) was approved in July 2025 for treating adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy.